Pre and post characterization of ODTs with emphasis on compression force and quality of super-disintegrants: In vivo analysis in healthy volunteers

Oral dispersible tablets (ODTs) are patient compliant dosage forms which rapidly disintegrate in the mouth following active absorption with rapid onset of action. The current study was designed to resolve compression problems used for ODTs, as high compression force exhibited hardness and drug relea...

Full description

Saved in:
Bibliographic Details
Published in:Pakistan journal of pharmaceutical sciences 2023-11, Vol.36 (6), p.1767-1775
Main Authors: Ayub, Shagufta, Hanif, Sana, Ul Huq, Umar Inzamam, Irfan, Muhammad, Ali, Ijaz, Madkhali, Osama A, Farzana, Kalsom, Ali Syed, Muhammad, Shahid, Nariman, Aftab, Tayyaba, Asmatullah, Maliha
Format: Article
Language:English
Subjects:
Chemical properties
Chemistry, Pharmaceutical - methods
Compressibility
Drug Compounding - methods
Excipients
Healthy Volunteers
Humans
Mechanical properties
Oral medication
Pharmaceutical research
Tablets
Tablets (Medicine)
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oral dispersible tablets (ODTs) are patient compliant dosage forms which rapidly disintegrate in the mouth following active absorption with rapid onset of action. The current study was designed to resolve compression problems used for ODTs, as high compression force exhibited hardness and drug release problems. Formulations, F1-F9 were compressed at three different forces 44, 54 and 64 kN using cross-carmellose sodium (CCS) and sodium starch glycolate (SSG) and evaluated for pre and post compression. Formulations F1, F4 and F7 which were compressed at 44 kN showed hardness ranges between 5.09-6.15 with lowest DT (less than 15 s) and better LTZ release. While F2, F5 and F8 (compressed at 54 kN) demonstrated hardness in between 6.90-7.02. Similarly, F3, F6 and F9 compressed at 64 kN showed hardness values between 8.70-8.98 with increased DT and slow LTZ release. Friability results for all the formulations were within United States Pharmacopeial (USP) specifications (
ISSN:1011-601X
DOI:10.36721/PJPS.2023.36.6.REG.1767-1775.1